Characterization, stabilization and activity of uricase loaded in lipid vesicles
- PMID: 19782743
- DOI: 10.1016/j.ijpharm.2009.09.036
Characterization, stabilization and activity of uricase loaded in lipid vesicles
Abstract
Uricase-containing lipid vesicles (UOXLVs) were prepared by reverse-phase evaporation method with high efficiency and the characteristics of UOXLVs were described. The average size and zeta potential of UOXLVs obtained by the optimized formulation were 205.47 nm and -37.33 mV, respectively. Uricase was encapsulated in the alkaline aqueous phase of the lipid vesicle and the stability of its tetrameric structure was thus improved and its activity preserved. The storage stability of uricase in lipid vesicles was significantly increased compared to that of free uricase at 4 degrees C in borate buffer of pH 8.5. At 55 degrees C, free uricase was deactivated much more quickly especially at lower concentration predominantly due to enhanced dissociation of uricase into subunits. An intrinsic tryptophan of uricase recovered from the lipid vesicle thermally treated at 55 degrees C revealed that a partially denatured uricase molecule was stabilized through its hydrophobic interaction with lipid vesicle membrane. This interaction was depressed mainly by dissociation of uricase into subunits. At the physiological pH, significant increase of enzyme activity was found for the uricase entrapped in the lipid vesicles (1.8 times that of free uricase) at their respective optimum pH. The shift of optimum pH and increased uricolytic activity suggested the conformation change of the uricase during the entrapment process. The stability to proteolytic digestion was increased obviously by entrapping the uricase in the lipid vesicles. UOXLVs also showed relatively slower loss in activity compared with free uricase when treated with some chemical reagents. Lastly, in vitro study explicitly indicated that the uricase entrapped by UOXLVs possessed higher uricolytic activity than that of native uricase solution.
Similar articles
-
Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.Int J Nanomedicine. 2012;7:3929-38. doi: 10.2147/IJN.S33835. Epub 2012 Jul 23. Int J Nanomedicine. 2012. PMID: 22915844 Free PMC article.
-
Preparation and characterization of lipid vesicles containing uricase.Drug Deliv. 2010 Jan;17(1):28-37. doi: 10.3109/10717540903508953. Drug Deliv. 2010. PMID: 22747073
-
Production of a thermostable uricase by a novel Bacillus thermocatenulatus strain.Bioresour Technol. 2008 Mar;99(4):699-702. doi: 10.1016/j.biortech.2007.01.048. Epub 2007 Mar 28. Bioresour Technol. 2008. PMID: 17395458
-
Immobilization of uricase upon polypyrrole-ferrocenium film.Artif Cells Blood Substit Immobil Biotechnol. 2007;35(6):607-20. doi: 10.1080/10731190701378634. Artif Cells Blood Substit Immobil Biotechnol. 2007. PMID: 18097787
-
Lipid vesicles and other colloids as drug carriers on the skin.Adv Drug Deliv Rev. 2004 Mar 27;56(5):675-711. doi: 10.1016/j.addr.2003.10.028. Adv Drug Deliv Rev. 2004. PMID: 15019752 Review.
Cited by
-
Nanosized sustained-release pyridostigmine bromide microcapsules: process optimization and evaluation of characteristics.Int J Nanomedicine. 2013;8:737-45. doi: 10.2147/IJN.S40860. Epub 2013 Feb 20. Int J Nanomedicine. 2013. PMID: 23459707 Free PMC article.
-
Urate crystal degradation for treatment of gout: a nanoparticulate combination therapy approach.Drug Deliv Transl Res. 2015 Jun;5(3):219-30. doi: 10.1007/s13346-015-0219-1. Drug Deliv Transl Res. 2015. PMID: 25787730
-
Improved biological properties and hypouricemic effects of uricase from Candida utilis loaded in novel alkaline enzymosomes.Int J Nanomedicine. 2012;7:3929-38. doi: 10.2147/IJN.S33835. Epub 2012 Jul 23. Int J Nanomedicine. 2012. PMID: 22915844 Free PMC article.
-
Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability.AAPS PharmSciTech. 2012 Jun;13(2):534-47. doi: 10.1208/s12249-012-9772-9. Epub 2012 Mar 28. AAPS PharmSciTech. 2012. PMID: 22454136 Free PMC article.
-
Rapidly separating dissolving microneedles with sustained-release colchicine and stabilized uricase for simplified long-term gout management.Acta Pharm Sin B. 2023 Aug;13(8):3454-3470. doi: 10.1016/j.apsb.2023.02.011. Epub 2023 Feb 24. Acta Pharm Sin B. 2023. PMID: 37655319 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources